Let’s start up with the current stock price of Sio Gene Therapies Inc. (SIOX), which is $0.30 to be very precise. The Stock rose vividly during the last session to $0.349 after opening rate of $0.335 while the lowest price it went was recorded $0.328 before closing at $0.35.Recently in News on August 11, 2022, Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results. — Strong cash position with $54.8 million of cash and cash equivalents as of June 30, 2022, expected to provide cash runway beyond August 2023. You can read further details here
Sio Gene Therapies Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.5250 on 01/03/22, with the lowest value was $0.2303 for the same time period, recorded on 05/12/22.
Sio Gene Therapies Inc. (SIOX) full year performance was -83.46%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Sio Gene Therapies Inc. shares are logging -88.75% during the 52-week period from high price, and 29.66% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.23 and $2.65.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 824312 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Sio Gene Therapies Inc. (SIOX) recorded performance in the market was -72.95%, having the revenues showcasing -5.55% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 25.76M, as it employees total of 12 workers.
Analysts verdict on Sio Gene Therapies Inc. (SIOX)
During the last month, 1 analysts gave the Sio Gene Therapies Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.3391, with a change in the price was noted -0.01. In a similar fashion, Sio Gene Therapies Inc. posted a movement of -2.45% for the period of last 100 days, recording 578,303 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SIOX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Sio Gene Therapies Inc. (SIOX): Technical Analysis
Raw Stochastic average of Sio Gene Therapies Inc. in the period of last 50 days is set at 16.01%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 19.21%. In the last 20 days, the company’s Stochastic %K was 38.24% and its Stochastic %D was recorded 41.81%.
Let’s take a glance in the erstwhile performances of Sio Gene Therapies Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -72.95%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -44.22%, alongside a downfall of -83.46% for the period of the last 12 months. The shares increased approximately by -2.16% in the 7-day charts and went down by 2.65% in the period of the last 30 days. Common stock shares were lifted by -5.55% during last recorded quarter.